A detailed history of Masters Capital Management LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Masters Capital Management LLC holds 1,200,000 shares of STIM stock, worth $756,000. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,200,000
Holding current value
$756,000
% of portfolio
0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.73 - $2.0 $876,000 - $2.4 Million
1,200,000 New
1,200,000 $912,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $17M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Masters Capital Management LLC Portfolio

Follow Masters Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Masters Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Masters Capital Management LLC with notifications on news.